As a participant in the Harvard Innovation Labs Venture Program Spring 2021, Promakhos Therapeutics has been selected as a semi-finalist for the Harvard President's Innovation Challenge - Health & Life Sciences track. The Innovation challenge is a call to action, innovation and entrepreneurship – and an opportunity to win up to $75,000 (Grand Prize) or $25,000 (Runner-up) in non-dilutive funding. In March, a second evaluation round will be held in which semi-finalists update the program with their company's progress. In this second round, 15 teams are ultimately selected to enter a final pitching competition hosted at the end of April.